These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37730473)

  • 1. Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis: A Retrospective Cohort Study.
    Chen Y; Zhu D; Chen M; Xu Y; Ye Q; Wang X; Xu P; Feng Q; Ji M; Wei Y; Fan J; Xu J
    Clin Colorectal Cancer; 2023 Dec; 22(4):464-473.e5. PubMed ID: 37730473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
    Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
    Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 4. Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery Chemotherapy.
    Datta J; Narayan RR; Goldman DA; Chatila WK; Gonen M; Strong J; Balachandran VP; Drebin JA; Kingham TP; Jarnagin WR; Schultz N; Kemeny NE; D'Angelica MI
    Ann Surg; 2022 Nov; 276(5):e474-e482. PubMed ID: 33214457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
    Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study.
    Chen Q; Zhang R; Xing B; Li C; Xiu D; Chen J; Deng Y; Chen X; Guo R; Chen F; Peng J; Sun T; Wang H; Li M; Zheng Q; Bi X; Zhao J; Zhou J; Li Z; Huang Z; Zhang Y; Zhang Y; Cai J; Zhao H
    Int J Surg; 2022 Oct; 106():106952. PubMed ID: 36220519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type of response to conversion chemotherapy strongly impacts survival after hepatectomy for initially unresectable colorectal liver metastases.
    Zimmitti G; Panettieri E; Ardito F; Rosso E; Mele C; Nuzzo G; Giuliante F
    ANZ J Surg; 2020 Apr; 90(4):558-563. PubMed ID: 31927783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors for early recurrence after hepatectomy for initially unresectable colorectal liver metastasis.
    Takahashi S; Konishi M; Kinoshita T; Gotohda N; Kato Y; Saito N; Sugito M; Yoshino T
    J Gastrointest Surg; 2013 May; 17(5):939-48. PubMed ID: 23400510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.
    Okuno M; Hatano E; Toda R; Nishino H; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokuka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
    J Hepatobiliary Pancreat Sci; 2020 Aug; 27(8):496-509. PubMed ID: 32362018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
    Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
    Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
    Hatano E; Okuno M; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):634-45. PubMed ID: 25926024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary approach to the diagnosis and treatment of patients with potentially resectable colorectal cancer liver metastasis: results of a multicenter study.
    Han L; Xue J; Wu X; Liang G; Wu Y; Guo F; Gao S; Sun G
    Ann Palliat Med; 2022 Feb; 11(2):717-729. PubMed ID: 35249349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.
    Sasaki K; Margonis GA; Andreatos N; Wilson A; Weiss M; Wolfgang C; Sergentanis TN; Polychronidis G; He J; Pawlik TM
    Br J Surg; 2017 Jun; 104(7):926-935. PubMed ID: 28266705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.
    Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M
    World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of autotransfusion on recurrence of colorectal cancer liver metastasis: Long-term follow-up of patients undergoing curative intent hepatectomy.
    Wehrle CJ; Perlmutter B; Hong H; Chang J; Stackhouse KA; Naples R; Shanaz Hossain M; Joyce D; Simon R; Kim J; Naffouje SA; Aucejo F; Kwon DCH; Walsh RM; Augustin T
    J Surg Oncol; 2024 Mar; 129(4):793-801. PubMed ID: 38151831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of R1 resection margin in synchronous and simultaneous colorectal liver metastasis resection: a retrospective cohort study.
    Kim NR; Alhothaifi ED; Han DH; Choi JS; Choi GH
    World J Surg Oncol; 2023 Jun; 21(1):169. PubMed ID: 37280633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of Clinical Efficacy of Thermal Ablation vs. Surgical Resection of Metachronous Colorectal Liver Metastasis].
    Yao ZH; Zhang K; Luo YG; Li YJ; Yang C; Yang HC; Cong TH; Li X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 May; 53(3):481-487. PubMed ID: 35642158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases-a Japanese Nationwide Survey.
    Kobayashi S; Beppu T; Honda G; Yamamoto M; Takahashi K; Endo I; Hasegawa K; Kotake K; Itabashi M; Hashiguchi Y; Kotera Y; Sakamoto K; Yamaguchi T; Morita S; Tabuchi K; Miyazaki M; Sugihara K
    J Gastrointest Surg; 2020 Jun; 24(6):1244-1260. PubMed ID: 31197683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical and oncologic outcomes following repeat hepatic resection of colorectal liver metastasis: Who benefits?
    Wong LH; Sutton TL; Walker BS; Lopez CD; Kardosh A; Eil RL; Chen EY; Billingsley KG; Mayo SC
    Am J Surg; 2021 Jun; 221(6):1114-1118. PubMed ID: 33722380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.